Form 4: Rallybio Director Ronald Hunt Acquires Options in Lieu of Retainer Fees
SEC Form 4 Filing
Director Ronald Hunt acquired options to purchase 73,571 shares of Rallybio Corp common stock in lieu of retainer fees.
Summary
- On January 2, 2025, Ronald Hunt, a director of Rallybio Corp, acquired options to purchase 73,571 shares of common stock.
- The options were granted at an exercise price of $0.95 per share and expire on January 2, 2035.
- The options vest in 12 equal monthly installments throughout 2025.
- These options were issued in lieu of $51,500 in retainer fees under the company's 2021 Equity Incentive Plan.
- Following the transaction, Hunt directly owns options for 73,571 shares.
Sentiment
Score: 7
Explanation: The sentiment is neutral to slightly positive. The director is increasing their stake in the company, which is generally a good sign. The use of options in lieu of cash is also a positive for the company's financial position.
Positives
- The acquisition of options by a director demonstrates their continued investment in the company's future.
- Using equity in lieu of cash retainer fees preserves the company's cash reserves.
Industry Context
This is a standard practice for compensating board members, particularly in smaller or growth-stage companies, to align their interests with those of shareholders and conserve cash.
Comparison to Industry Standards
- Granting options to directors is a common practice, especially in biotech companies like Rallybio, to align their interests with shareholders.
- The vesting schedule of 12 months is also fairly standard.
- Comparable companies such as BioNTech or Moderna also utilize equity-based compensation for their board members.
Related Party Transactions
- The grant of options to Ronald Hunt, a director, in lieu of retainer fees is a related party transaction.
Stakeholder Impact
- Shareholders may view this positively as it aligns the director's interests with theirs and conserves company cash.
- Employees may see this as a sign of confidence in the company's future.
Key Dates
| Date | Description |
|---|---|
| 01/02/2025 | Date of the transaction: Ronald Hunt acquired options to purchase Rallybio Corp common stock. |
| 01/02/2025 | Option grant date and first vesting date. |
| 01/06/2025 | Date of signature on the Form 4 filing. |
| 01/02/2035 | Expiration date of the options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.